Immuneering Corp 10-Q

Item 5. Other Information None. Item 6. Exhibits ​ EXHIBIT INDEX ​ ​ ​ ​ ​ ​ ​ Incorporated by Reference Filed/ Exhibit Number Exhibit Description Form File No. Exhibit Filing Date Furnished Herewith ​ ​ ​ ​ ​ ​ ​ 3.1 Amended and Restated Certificate of Incorporation of Immuneering Corporation 10-Q 001-40675 3.1 9/9/2021 3.2 Amended and Restated Bylaws of Immuneering Corporation 10-Q 001-40675 3.2 9/9/2021 10.1† Employment Agreement, dated July 23, 2021, by and between Biren Amin and Immuneering Corporation S-1/A 333-257791 10.5 07/26/2021 ​ 10.2† E mployment Agreement, dated July 23, 2021, by and between Brett Hall, Ph.D. and Immuneering Corporation S-1/A 333-257791 10.6 07/26/2021 ​ 10.3† E mployment Agreement, dated July 23, 2021, by and between Scott Barrett, M.D. and Immuneering Corporation S-1/A 333-257791 10.7 07/26/2021 ​ 101 Table of Contents ​ ​ ​ ​ ​ ​ Incorporated by Reference Filed/ Exhibit Number Exhibit Description Form File No. Exhibit Filing Date Furnished Herewith ​ ​ ​ ​ ​ ​ ​ 10.4† E mployment Agreement, dated July 23, 2021, by and between Benjamin J. Zeskind, Ph.D. and Immuneering Corporation S-1/A 333-257791 10.8 07/26/2021 ​ 10.5† E mployment Agreement, dated July 23, 2021, by and between Michael D. Bookman and Immuneering Corporation S-1/A 333-257791 10.9 07/26/2021 ​ 10.6† Immuneering Corporation 2021 Incentive Award Plan and forms of award agreements thereunder. S-1/A 333-257791 10.10 07/26/2021 ​ 10.7† Immuneering Corporation 2021 Employee Stock Purchase Plan. S-1/A 333-257791 10.11 07/26/2021 ​ 10.8† Form of Indemnification Agreement by and among the Registrant and its directors and officers. S-1/A 333-257791 10.12 07/26/2021 ​ 10.9† Immuneering Corporation Non-Employee Director Compensation Program. S-1/A 333-257791 10.13 07/26/2021 ​ 31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a). ​ ​ ​ ​ * 31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a). ​ ​ ​ ​ * 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. ​ ​ ​ ​ ** 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. ​ ​ ​ ​ ** 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. ​ ​ ​ ​ * 101.SCH Inline XBRL Taxonomy Extension Schema Document. ​ ​ ​ ​ * 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. ​ ​ ​ ​ * 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. ​ ​ ​ ​ * 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. ​ ​ ​ ​ * 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. ​ ​ ​ ​ * 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) ​ ​ ​ ​ * ​ * Filed herewith. ** Furnished herewith. † Indicates a management contract or compensatory plan or arrangement. ​ 102 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized. ​ ​ ​ ​ ​ IMMUNEERING CORPORATION ​ ​ ​ Date: November 9, 2021 By: /s/ Benjamin J. Zeskind ​ Name: Benjamin J. Zeskind, Ph.D. ​ Title: Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer) ​ ​ ​ ​ ​ ​ ​ Date: November 9, 2021 By: /s/ Biren Amin ​ Name: Biren Amin ​ Title: Chief Financial Officer and Treasurer ​ ​ (Principal Financial Officer and Principal Accounting Officer) ​ ​ ​ ​ ​ 103